Published in Methods Mol Biol on January 01, 2009
Stem cells and liver regeneration. Gastroenterology (2009) 3.40
Amnion-derived stem cells: in quest of clinical applications. Stem Cell Res Ther (2011) 1.05
Placental stem cell correction of murine intermediate maple syrup urine disease. Hepatology (2013) 0.89
Amniotic mesenchymal stem cells: a new source for hepatocyte-like cells and induction of CFTR expression by coculture with cystic fibrosis airway epithelial cells. J Biomed Biotechnol (2012) 0.82
Human amniotic epithelial cells cultured in substitute serum medium maintain their stem cell characteristics for up to four passages. Int J Stem Cells (2011) 0.80
Applications of amniotic membrane and fluid in stem cell biology and regenerative medicine. Stem Cells Int (2012) 0.80
Effect of Culture Conditions on Reference Genes Expression in Placenta-derived Stem Cells. Int J Stem Cells (2009) 0.78
Transplantation of human amniotic epithelial cells repairs brachial plexus injury: pathological and biomechanical analyses. Neural Regen Res (2014) 0.76
Placental amniotic epithelial cells and their therapeutic potential in liver diseases. Front Med (Lausanne) (2014) 0.75
Hepatocyte Transplantation in Special Populations: Clinical Use in Children. Methods Mol Biol (2017) 0.75
Amniotic Epithelial Cells: A New Tool to Combat Aging and Age-Related Diseases? Front Cell Dev Biol (2016) 0.75
Hepatocyte-like cells derived from human amniotic epithelial cells can be encapsulated without loss of viability or function in vitro. Stem Cells Dev (2014) 0.75
Mapping the genetic architecture of gene expression in human liver. PLoS Biol (2008) 19.44
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol (2007) 5.04
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells (2007) 3.39
Human hepatocyte transplantation: worldwide results. Transplantation (2006) 3.02
Stem cell characteristics of amniotic epithelial cells. Stem Cells (2005) 2.66
Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver. Genome Res (2010) 2.06
Hepatic CYP2B6 expression: gender and ethnic differences and relationship to CYP2B6 genotype and CAR (constitutive androstane receptor) expression. J Pharmacol Exp Ther (2003) 1.94
A whole-organ regenerative medicine approach for liver replacement. Tissue Eng Part C Methods (2011) 1.60
Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng Part A (2010) 1.50
Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics (2003) 1.49
Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev (2006) 1.48
Identification of oxysterol 7alpha-hydroxylase (Cyp7b1) as a novel retinoid-related orphan receptor alpha (RORalpha) (NR1F1) target gene and a functional cross-talk between RORalpha and liver X receptor (NR1H3). Mol Pharmacol (2007) 1.46
Barriers to the successful treatment of liver disease by hepatocyte transplantation. J Hepatol (2010) 1.41
PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol (2004) 1.37
The uremic toxin 3-indoxyl sulfate is a potent endogenous agonist for the human aryl hydrocarbon receptor. Biochemistry (2010) 1.32
Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31
Clinical and histological characterization of liver disease in patients with transfusion-dependent beta-thalassemia. A multicenter study of 117 cases. Haematologica (2004) 1.30
Frequent aneuploidy among normal human hepatocytes. Gastroenterology (2011) 1.30
Gene expression profiling and differentiation assessment in primary human hepatocyte cultures, established hepatoma cell lines, and human liver tissues. Toxicol Appl Pharmacol (2007) 1.29
Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metab Dispos (2004) 1.19
Toward cell therapy using placenta-derived cells: disease mechanisms, cell biology, preclinical studies, and regulatory aspects at the round table. Stem Cells Dev (2010) 1.17
Human hepatocyte transplantation. Methods Mol Biol (2010) 1.17
Development and application of purified tissue dissociation enzyme mixtures for human hepatocyte isolation. Cell Transplant (2011) 1.16
Regulation of human hepatic hydroxysteroid sulfotransferase gene expression by the peroxisome proliferator-activated receptor alpha transcription factor. Mol Pharmacol (2005) 1.14
A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine. Drug Metab Dispos (2008) 1.14
Isolated hepatocyte transplantation for Crigler-Najjar syndrome type 1. Cell Transplant (2005) 1.12
Chimeric mice with humanized liver: tools for the study of drug metabolism, excretion, and toxicity. Methods Mol Biol (2010) 1.11
ChREBP mediates glucose-stimulated pancreatic β-cell proliferation. Diabetes (2012) 1.08
Evaluation of hepatotoxic potential of drugs by inhibition of bile-acid transport in cultured primary human hepatocytes and intact rats. Toxicol Sci (2003) 1.08
Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection. World J Surg (2008) 1.08
Positive and negative regulation of human hepatic hydroxysteroid sulfotransferase (SULT2A1) gene transcription by rifampicin: roles of hepatocyte nuclear factor 4alpha and pregnane X receptor. J Pharmacol Exp Ther (2007) 1.07
Identification of stem cell marker-positive cells by immunofluorescence in term human amnion. J Reprod Immunol (2007) 1.06
MicroRNA hsa-miR-613 targets the human LXRα gene and mediates a feedback loop of LXRα autoregulation. Mol Endocrinol (2011) 1.05
Hepatocyte transplantation: clinical experience and potential for future use. Cell Transplant (2006) 1.05
Effects of bergamottin on human and monkey drug-metabolizing enzymes in primary cultured hepatocytes. Drug Metab Dispos (2002) 1.04
Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol Sci (2010) 1.03
FoxO6 integrates insulin signaling with gluconeogenesis in the liver. Diabetes (2011) 1.03
Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol (2010) 1.03
Side population cells derived from adult human liver generate hepatocyte-like cells in vitro. Dig Dis Sci (2005) 1.02
Isolation of amniotic epithelial stem cells. Curr Protoc Stem Cell Biol (2007) 1.01
Hepatic differentiation of amniotic epithelial cells. Hepatology (2011) 0.99
Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone. Toxicol Sci (2006) 0.99
Mouse fetal liver cells in artificial capillary beds in three-dimensional four-compartment bioreactors. Am J Pathol (2005) 0.97
A functional polymorphism at the transcriptional initiation site in beta2-glycoprotein I (apolipoprotein H) associated with reduced gene expression and lower plasma levels of beta2-glycoprotein I. Eur J Biochem (2003) 0.96
Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol Ther (2009) 0.96
Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures. Toxicol Appl Pharmacol (2008) 0.96
Phenobarbital and phenytoin increased acetaminophen hepatotoxicity due to inhibition of UDP-glucuronosyltransferases in cultured human hepatocytes. Toxicol Sci (2005) 0.94
Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD). Biochim Biophys Acta (2009) 0.94
Metabolism of 17alpha-hydroxyprogesterone caproate, an agent for preventing preterm birth, by fetal hepatocytes. Drug Metab Dispos (2010) 0.93
New potential cell source for hepatocyte transplantation: discarded livers from metabolic disease liver transplants. Stem Cell Res (2013) 0.92
Isolation of amniotic mesenchymal stem cells. Curr Protoc Stem Cell Biol (2010) 0.92
A pregnane X receptor agonist with unique species-dependent stereoselectivity and its implications in drug development. Mol Pharmacol (2005) 0.92
The second extracellular loop dictates Occludin-mediated HCV entry. Virology (2010) 0.92
Regulation of CYP2B6 and CYP3A expression by hydroxymethylglutaryl coenzyme A inhibitors in primary cultured human hepatocytes. Drug Metab Dispos (2002) 0.91
Antiviral activity of benzimidazole derivatives. I. Antiviral activity of 1-substituted-2-[(benzotriazol-1/2-yl)methyl]benzimidazoles. Chem Biodivers (2008) 0.90
In vitro expansion of human hepatocytes is restricted by telomere-dependent replicative aging. Cell Transplant (2003) 0.89
Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures. Clin Cancer Res (2005) 0.89
Placental stem cell correction of murine intermediate maple syrup urine disease. Hepatology (2013) 0.89
Microencapsule technique protects hepatocytes from cryoinjury. Hepatol Res (2007) 0.89
Improved amino acid, bioenergetic metabolite and neurotransmitter profiles following human amnion epithelial cell transplant in intermediate maple syrup urine disease mice. Mol Genet Metab (2013) 0.88
Melatonin expresses powerful anti-inflammatory and antioxidant activities resulting in complete improvement of acetic-acid-induced colitis in rats. Dig Dis Sci (2010) 0.87
Preservation of hepatic phenotype in lentiviral-transduced primary human hepatocytes. Chem Biol Interact (2008) 0.87
Translation of amnion stem cells to the clinic. Stem Cells Dev (2013) 0.87
Hepatobiliary disposition of 17-OHPC and taurocholate in fetal human hepatocytes: a comparison with adult human hepatocytes. Drug Metab Dispos (2012) 0.85
Genetic variation in aldo-keto reductase 1D1 (AKR1D1) affects the expression and activity of multiple cytochrome P450s. Drug Metab Dispos (2013) 0.85
FoxO1 links hepatic insulin action to endoplasmic reticulum stress. Endocrinology (2010) 0.84
Regulation of the human hydroxysteroid sulfotransferase (SULT2A1) by RORα and RORγ and its potential relevance to human liver diseases. Mol Endocrinol (2012) 0.84
Arsenite decreases CYP3A4 and RXRalpha in primary human hepatocytes. Drug Metab Dispos (2005) 0.84
Study of the genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes. Pharmacogenet Genomics (2006) 0.84
Hepatocyte senescence in vivo following preconditioning for liver repopulation. Hepatology (2012) 0.84
Clinical hepatocyte transplantation: practical limits and possible solutions. Eur Surg Res (2015) 0.84